Duplication errors due to brand name confusion; It is not always the name-Short case series

dc.contributor.authorMamunuwa, N.
dc.contributor.authorJayamanne, S.
dc.contributor.authorWijekoon, N.
dc.contributor.authorCoombes, J.
dc.contributor.authorPerera, D.
dc.contributor.authorShanika, T.
dc.contributor.authorMohamed, F.
dc.contributor.authorLynch, C.
dc.contributor.authorde Silva, A.
dc.contributor.authorDawson, A.
dc.date.accessioned2023-09-19T09:11:18Z
dc.date.available2023-09-19T09:11:18Z
dc.date.issued2023
dc.descriptionNot indexed in MEDLINE.en_US
dc.description.abstractConfusion of drug names has been identified as a leading cause of medication errors and potential iatrogenic harm. Most of these errors occur because of look-alike or sound-alike drugs. This case series gives examples of duplication errors due to brand confusion, where there are no similarities in the names.en_US
dc.identifier.citationClinical Case Reports.2023;11(9):e7795.en_US
dc.identifier.issn2050-0904 (Electronic)
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/26538
dc.language.isoenen_US
dc.publisherJohn Wiley & Sonsen_US
dc.subjectbrand confusionen_US
dc.subjectduplication errorsen_US
dc.subjectmedication errors.en_US
dc.titleDuplication errors due to brand name confusion; It is not always the name-Short case seriesen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
52 B
Format:
Item-specific license agreed upon to submission
Description: